消息面上,晶泰科技近日与杭州百诚医药科技股份有限公司宣布签订合作意向书。根据合作意向书,百诚医药委托晶泰科技,利用其 “AI+机器人” 平台开展新药研发工作;晶泰科技将委托百诚医药开展药学研究等研发工作。双方还计划针对疼痛、嗜睡、肿瘤、自免、眼科等多个疾病领域尚未满足的临床需求,借助晶泰科技的 AI 药物研发平台,共同推进创新药管线的研发与孵化,并择机成立合资公司,探索更广领域的商业合作。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.